VEGFA and age-related macular degeneration: Age-related macular degeneration (AMD) is one of the principal causes of visual impairment among aged population in developed countries.1 Therapies targeting vascular endothelial growth factor substantially improve the visual acuity of patients with exudative/wet AMD.